The absolute counts of total lymphocytes, T cells (CD3+), CD4+ T cells, CD8+ T cells, and CD4−CD8− T cells showed a progressive and statistically significant decline from HCs to newly diagnosed AML patients and further to nonremission patients (p < 0.001 for all comparisons; Table 3). The gene discussed is CD8A; the disease is acute myeloid leukemia.